Next Article in Journal
Pre-Op Hydronephrosis Predicts Outcomes in Patients Receiving Robot-Assisted Radical Cystectomy
Previous Article in Journal
Mitochondrial Dynamics in Non-Small Cell Lung Cancer
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cancers
Volume 16
Issue 16
10.3390/cancers16162824
cancers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Cancers 2023, 15(2), 417.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Li et al. TRIM10 Is Downregulated in Acute Myeloid Leukemia and Plays a Tumor Suppressive Role via Regulating NF-κB Pathway. Cancers 2023, 15, 417

by
Lin Li
1,2,
Qi Li
3,
Zhengrong Zou
4,
Zoufang Huang
2 and
Yijian Chen
1,2,*
1
Suzhou Medical College of Soochow University, Suzhou 215123, China
2
Department of Hematology, The First Affiliated Hospital of Gannan Medical University, Ganzhou 341000, China
3
Basic Medicine Department, Chuxiong Medical and Pharmaceutical College, Chuxiong 675005, China
4
Department of Emergency, The First Affiliated Hospital of Gannan Medical University, Ganzhou 341000, China
*
Author to whom correspondence should be addressed.
Cancers 2024, 16(16), 2824; https://doi.org/10.3390/cancers16162824
Submission received: 8 May 2024 / Accepted: 5 July 2024 / Published: 12 August 2024
Browse Figure
Versions Notes

Error in Figure

In the original publication [1], there was a mistake in Figure 6G, the CHI 1 μM group of K562 cells as published. Making a mistake of placing a duplicate flow chart of (Figure 3E, the Vector group of HL60 cells) in the place of (Figure 6G, the CHI 1 μM group of K562 cells). The corrected Figure 6G, the CHI 1 μM group of K562 cells appears below. The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Li, L.; Li, Q.; Zou, Z.; Huang, Z.; Chen, Y. TRIM10 Is Downregulated in Acute Myeloid Leukemia and Plays a Tumor Suppressive Role via Regulating NF-κB Pathway. Cancers 2023, 15, 417. [Google Scholar] [CrossRef] [PubMed]
Cancers 16 02824 g006
Figure 6. Combination of azacitidine (AZA) and chidamide (CHI) results in upregulation of TRIM10 expression and remarkable apoptosis in AML cells. (A,B) qRT-PCR analysis of TRIM10 expression after treatment with different dose of CHI for 48 h. (C,D) qRT-PCR analysis of TRIM10 expression after treatment with different dose of azacitidine for 48 h. (E,F) qRT-PCR analysis of TRIM10 expression after treatment with 5 μM azacitidine and 1 μM chidamide singly or in combination for 48 h. (G,H) Annexin V-PE/7-AAD double staining analysis of HL60 and K562 cells treated with 5 μM azacitidine and/or 1 μM chidamide for 48 h. Percentages of AML cell apoptosis based on three independent experiments. * p < 0.05; ** p < 0.01 (Student’s t-test).
Figure 6. Combination of azacitidine (AZA) and chidamide (CHI) results in upregulation of TRIM10 expression and remarkable apoptosis in AML cells. (A,B) qRT-PCR analysis of TRIM10 expression after treatment with different dose of CHI for 48 h. (C,D) qRT-PCR analysis of TRIM10 expression after treatment with different dose of azacitidine for 48 h. (E,F) qRT-PCR analysis of TRIM10 expression after treatment with 5 μM azacitidine and 1 μM chidamide singly or in combination for 48 h. (G,H) Annexin V-PE/7-AAD double staining analysis of HL60 and K562 cells treated with 5 μM azacitidine and/or 1 μM chidamide for 48 h. Percentages of AML cell apoptosis based on three independent experiments. * p < 0.05; ** p < 0.01 (Student’s t-test).
Cancers 16 02824 g006
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Li, L.; Li, Q.; Zou, Z.; Huang, Z.; Chen, Y. Correction: Li et al. TRIM10 Is Downregulated in Acute Myeloid Leukemia and Plays a Tumor Suppressive Role via Regulating NF-κB Pathway. Cancers 2023, 15, 417. Cancers 2024, 16, 2824. https://doi.org/10.3390/cancers16162824

AMA Style

Li L, Li Q, Zou Z, Huang Z, Chen Y. Correction: Li et al. TRIM10 Is Downregulated in Acute Myeloid Leukemia and Plays a Tumor Suppressive Role via Regulating NF-κB Pathway. Cancers 2023, 15, 417. Cancers. 2024; 16(16):2824. https://doi.org/10.3390/cancers16162824

Chicago/Turabian Style

Li, Lin, Qi Li, Zhengrong Zou, Zoufang Huang, and Yijian Chen. 2024. "Correction: Li et al. TRIM10 Is Downregulated in Acute Myeloid Leukemia and Plays a Tumor Suppressive Role via Regulating NF-κB Pathway. Cancers 2023, 15, 417" Cancers 16, no. 16: 2824. https://doi.org/10.3390/cancers16162824

APA Style

Li, L., Li, Q., Zou, Z., Huang, Z., & Chen, Y. (2024). Correction: Li et al. TRIM10 Is Downregulated in Acute Myeloid Leukemia and Plays a Tumor Suppressive Role via Regulating NF-κB Pathway. Cancers 2023, 15, 417. Cancers, 16(16), 2824. https://doi.org/10.3390/cancers16162824

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop